Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,700 | 20 | 65.2% |
| Travel and Lodging | $8,081 | 45 | 12.6% |
| Consulting Fee | $5,106 | 3 | 8.0% |
| Food and Beverage | $4,981 | 176 | 7.8% |
| Honoraria | $3,000 | 1 | 4.7% |
| Education | $568.53 | 71 | 0.9% |
| Gift | $495.33 | 30 | 0.8% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $60,136 | 162 | $0 (2020) |
| ABBVIE INC. | $1,011 | 38 | $0 (2024) |
| Allergan, Inc. | $593.03 | 27 | $0 (2022) |
| Cerner Corporation | $450.00 | 1 | $0 (2020) |
| Avion Pharmaceuticals | $261.97 | 15 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $138.99 | 6 | $0 (2022) |
| ASCEND THERAPEUTICS US, LLC | $130.04 | 41 | $0 (2023) |
| Shionogi Inc | $128.09 | 2 | $0 (2017) |
| Pacira Pharmaceuticals Incorporated | $123.93 | 1 | $0 (2018) |
| TherapeuticsMD, Inc. | $111.44 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $218.35 | 10 | ABBVIE INC. ($218.35) |
| 2023 | $121.25 | 5 | ABBVIE INC. ($74.45) |
| 2022 | $802.27 | 71 | ABBVIE INC. ($221.22) |
| 2021 | $312.71 | 17 | AbbVie Inc. ($127.17) |
| 2020 | $702.78 | 13 | Cerner Corporation ($450.00) |
| 2019 | $1,556 | 42 | AMAG Pharmaceuticals, Inc. ($979.93) |
| 2018 | $17,754 | 69 | AMAG Pharmaceuticals, Inc. ($17,226) |
| 2017 | $42,465 | 121 | AMAG Pharmaceuticals, Inc. ($41,915) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.53 | General |
| 06/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.35 | General |
| 04/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.58 | General |
| 04/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/19/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/27/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.04 | General |
| 07/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: Biological | ||||||
| 03/07/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Women's Health | ||||||
| 02/07/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: WOMENS HEALTH | ||||||
| 12/15/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $24.37 | General |
| 12/12/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Women's Health | ||||||
| 12/07/2022 | Mylan Pharmaceuticals Inc. | Xulane (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Contraceptives, Transdermal | ||||||
| 12/07/2022 | ABBVIE INC. | ORILISSA (Drug), ORIAHNN, LO LOESTRIN FE | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: WOMENS HEALTH | ||||||
| 12/06/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $22.32 | General |
| 11/18/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $29.92 | General |
| 11/17/2022 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: WOMENS HEALTH | ||||||
| 11/11/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.77 | General |
| Category: Women's Health | ||||||
| 11/02/2022 | Avion Pharmaceuticals | Divigel (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Hormone Replacement Therapy | ||||||
| 10/26/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Women's Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 294 | 301 | $54,185 | $16,419 |
| 2022 | 8 | 590 | 663 | $107,600 | $43,094 |
| 2021 | 9 | 542 | 598 | $97,038 | $36,462 |
| 2020 | 6 | 255 | 278 | $40,670 | $16,669 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 77 | 77 | $7,691 | $3,629 | 47.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 80 | 80 | $5,670 | $3,310 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 61 | $12,193 | $3,284 | 26.9% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 31 | 32 | $11,604 | $2,576 | 22.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 31 | 32 | $12,314 | $2,571 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,713 | $1,050 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 148 | $25,900 | $10,344 | 39.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 141 | 141 | $10,575 | $6,543 | 61.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 150 | 150 | $6,750 | $6,196 | 91.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 53 | 60 | $21,000 | $5,676 | 27.0% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 51 | 57 | $19,950 | $5,065 | 25.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 53 | 53 | $11,925 | $4,499 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 41 | $9,225 | $3,804 | 41.2% |
| 58100 | Biopsy of lining of uterus | Office | 2022 | 13 | 13 | $2,275 | $967.51 | 42.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 110 | $18,990 | $7,267 | 38.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 133 | 133 | $9,975 | $6,247 | 62.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 134 | 134 | $6,030 | $5,585 | 92.6% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 52 | 56 | $19,600 | $5,402 | 27.6% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 51 | 58 | $20,300 | $5,377 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 29 | $6,525 | $2,988 | 45.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $8,550 | $2,570 | 30.1% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 21 | 21 | $4,580 | $654.74 | 14.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 19 | 19 | $2,488 | $370.98 | 14.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 68 | $10,540 | $3,892 | 36.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 73 | 73 | $5,475 | $3,389 | 61.9% |
About Dr. Bryan Jick, MD
Dr. Bryan Jick, MD is a Obstetrics & Gynecology healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720051436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Jick, MD has received a total of $63,932 in payments from pharmaceutical and medical device companies, with $218.35 received in 2024. These payments were reported across 348 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,700).
As a Medicare-enrolled provider, Jick has provided services to 1,681 Medicare beneficiaries, totaling 1,840 services with total Medicare billing of $112,644. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Pasadena, CA
- Active Since 02/12/2006
- Last Updated 02/02/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1720051436
Products in Payments
- MAKENA (Drug) $51,749
- LO LOESTRIN FE (Drug) $292.84
- Lupron (Drug) $240.71
- INTRAROSA (Drug) $210.51
- BOTOX (Biological) $201.60
- ORILISSA (Drug) $197.51
- Balcoltra (Drug) $135.87
- Orilissa (Drug) $128.81
- Osphena (Drug) $128.09
- EXPAREL (Drug) $123.93
- ESTROGEL (Drug) $106.55
- Prenate Mini (Drug) $105.96
- DIVIGEL (Drug) $97.46
- BOTOX COSMETIC (Biological) $90.69
- Kyleena (Drug) $76.66
- ANNOVERA (Drug) $66.19
- CitraNatal (Drug) $65.82
- Mirena (Drug) $62.33
- Vitafol Ultra (Drug) $50.53
- MYFEMBREE (Drug) $48.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Pasadena
David Kimble, Md, MD
Obstetrics & Gynecology — Payments: $33,099
Dr. Fernando Ocon, M.d, M.D
Obstetrics & Gynecology — Payments: $19,637
Bassem Tawadrous, M.d, M.D
Obstetrics & Gynecology — Payments: $18,497
Dr. Subha Sundaram, Md, MD
Obstetrics & Gynecology — Payments: $14,809
Dr. George Matsuda, Md, MD
Obstetrics & Gynecology — Payments: $13,297
Deya Dafashy, M.d, M.D
Obstetrics & Gynecology — Payments: $10,743